Chesapeake Asset Management LLC Sanofi Transaction History

Chesapeake Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Jan 05, 2026	SELL	$48.15 - $59.42 $1,637 - $2,020	-34 Reduced 37.36%	57 $3.16 Million
Q2 2024 Jan 05, 2026	BUY	$45.39 - $50.36 $4,130 - $4,582	91 New	91 $4.42 Million
Q4 2023 Jan 05, 2026	SELL	$43.13 - $54.79 $10,351 - $13,149	-240 Reduced 72.51%	91 $4.53 Million
Q3 2023 Jan 05, 2026	BUY	$50.95 - $55.2 $4,636 - $5,023	91 Added 37.92%	331 $17.8 Million
Q1 2023 Jan 05, 2026	BUY	$45.86 - $54.45 $11,006 - $13,068	240 New	240 $13.1 Million

829

250M

2.45M

2.51M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Asset Management LLC with notifications on news.